Device type · OQY
Intrauterine Tamponade Balloon
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OQY
Obstetrics & Gynecology
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
102
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Intrauterine Tamponade Balloon
- Product code
- OQY
- Device class
- Class II
- Review panel
- Obstetrics & Gynecology
- Regulation
- 21 CFR 884.4530
- Specialty
- Obstetrics & Gynecology
- FDA record
- Classification database entry for OQY
Latest FDA decisions
The 8 newest of 9 since 2015.
- Jada System (Jada-2002)510(k)
K253642 · Decided May 15, 2026 · 177 days after receipt
Device type: Intrauterine Tamponade Balloon (OQY) · Obstetrics & Gynecology
- ELLAVI UBT510(k)
Sinapi Biomedical (Pty) , Ltd.
K230849 · Decided Nov 13, 2023 · 230 days after receipt
Device type: Intrauterine Tamponade Balloon (OQY) · Obstetrics & Gynecology
K223098 · Decided Oct 28, 2022 · 28 days after receipt
Device type: Intrauterine Tamponade Balloon (OQY) · Obstetrics & Gynecology
6 more FDA decisions with a free account
Reports received
102
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
75
74% of reports
Injury reports
24
24% of reports
Death reports
3
2.9% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 10 | 6 | 0 | 0 |
| Jan 24 | 8 | 2 | 0 | 0 |
| Feb 24 | 8 | 13 | 0 | 0 |
| Mar 24 | 8 | 13 | 0 | 0 |
| Apr 24 | 10 | 15 | 0 | 0 |
| May 24 | 7 | 10 | 0 | 0 |
| Jun 24 | 6 | 4 | 0 | 0 |
| Jul 24 | 5 | 18 | 0 | 0 |
| Aug 24 | 14 | 9 | 1 | 0 |
| Sep 24 | 12 | 11 | 0 | 0 |
| Oct 24 | 11 | 9 | 1 | 0 |
| Nov 24 | 4 | 8 | 0 | 0 |
| Dec 24 | 5 | 1 | 2 | 0 |
| Jan 25 | 8 | 4 | 0 | 0 |
| Feb 25 | 6 | 2 | 0 | 0 |
| Mar 25 | 5 | 46 | 0 | 0 |
| Apr 25 | 7 | 8 | 0 | 0 |
| May 25 | 13 | 6 | 0 | 0 |
| Jun 25 | 8 | 6 | 0 | 0 |
| Jul 25 | 5 | 7 | 0 | 0 |
| Aug 25 | 7 | 7 | 0 | 0 |
| Sep 25 | 2 | 2 | 2 | 0 |
| Oct 25 | 9 | 3 | 0 | 0 |
| Nov 25 | 5 | 2 | 0 | 0 |
| Dec 25 | 9 | 1 | 0 | 0 |
| Jan 26 | 7 | 4 | 0 | 0 |
| Feb 26 | 4 | 1 | 1 | 0 |
| Mar 26 | 6 | 1 | 1 | 0 |
| Apr 26 | 8 | 4 | 0 | 0 |
| May 26 | 6 | 4 | 0 | 0 |
| Jun 26 | 5 | 1 | 0 | 0 |
| Jul 26 | 5 | 1 | 0 | 0 |
| Aug 26 | 10 | 2 | 1 | 0 |
| Sep 26 | 5 | 1 | 0 | 0 |
| Oct 26 | 5 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Cook91
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak58
- Material Rupture10
- Adverse Event Without Identified Device or Use Problem8
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions81
- Insufficient Information10
- Hemorrhage/Blood Loss/Bleeding9
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0123-2016 · Started Jan 5, 2015 · Posted by FDA Oct 15, 2015
Reason given: Clinical Innovations, LLC is voluntarily recalling the Ebb Complete Tamponade System (CTS-1000) Lot Number 1214-F-403.) to address the potential for a balloon leak which may affect the ability to deliver therapy, when needed.
Cause as FDA categorized it: Other
- Ebb Complete Tamponade System, BD-OTS Obstetric Catheter, REF CTS-1000, Rx Only, Sterile EOTerminated
Z-1014-2015 · Started Dec 30, 2014 · Posted by FDA Jan 27, 2015
Reason given: Potential for a balloon leak in all lots of (CTS-1000) manufactured since August 2014.
Cause as FDA categorized it: Process design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.